Drug Shortage Report for VALCYTE
| Report ID | 191497 |
| Drug Identification Number | 02306085 |
| Brand name | VALCYTE |
| Common or Proper name | Valganciclovir Powder for Oral Solution |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | VALGANCICLOVIR |
| Strength(s) | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | 5 g valganciclovir / bottle |
| ATC code | J05AB |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-05-02 |
| Estimated end date | 2023-11-30 |
| Actual end date | 2023-11-02 |
| Shortage status | Resolved |
| Updated date | 2023-11-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-11-05 | French | Compare |
| v6 | 2023-11-05 | English | Compare |
| v5 | 2023-10-26 | French | Compare |
| v4 | 2023-10-26 | English | Compare |
| v3 | 2023-05-03 | English | Compare |
| v2 | 2023-05-02 | French | Compare |
| v1 | 2023-05-02 | English | Compare |
Showing 1 to 7 of 7